Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Neothermia Corp. · Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

15 daysmedian FDA review time
243 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K041347MODIFICATION TO EN-BLOC BIOPSY SYSTEMNeothermia Corp.2004-06-04150
K033427MODIFICATION TO EN-BLOC BIOPSY SYSTEMNeothermia Corp.2003-11-10130
K023413MODIFICATION TO NEOTHERMIA'S EN-BLOC BIOPSY SYSTEMNeothermia Corp.2002-11-08280
K022296MODIFICATION TO EN-BLOC BIOPSY SYSTEMNeothermia Corp.2002-07-30140
K021577MODIFICATION TO EN-BLOC BIOPSY SYSTEMNeothermia Corp.2002-05-29150
K020031EN-BLOC BIOPSY SYSTEM, MODELS 777-110, 777-120, 770-001, 777Neothermia Corp.2002-03-27820
K003190EN BLOC BIOPSY SYSTEMNeothermia Corp.2001-06-1124311

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda